WCG
ABMD

Weaver Consulting Group’s Abiomed Inc ABMD Stock Holding History

Weaver Consulting Group’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-20
Closed -$6K – 981
2020
Q3 		$6K Hold
20
– – ﹤0.01% 674
2020
Q2 		$5K Hold
20
– – ﹤0.01% 679
2020
Q1 		$3K Buy
20
+7
+54% +$1.16K ﹤0.01% 678
2019
Q4 		$2K Hold
13
– – ﹤0.01% 770
2019
Q3 		$4K Hold
13
– – ﹤0.01% 657
2019
Q2 		$3K Hold
13
– – ﹤0.01% 685
2019
Q1 		$4K Buy
+13
New +$4.32K ﹤0.01% 1184

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Weaver Consulting Group's ABMD Position: Q4 2020 in Review

Weaver Consulting Group sold out of Abiomed Inc (ABMD) in Q4 2020, closing a stake of 20 shares — an estimated $6K sold.

Weaver Consulting Group first reported a position in ABMD in Q1 2019 and held it in 7 quarters. The position peaked at $6K in Q3 2020. 498 funds tracked by Wall St. Rank hold ABMD as of Q4 2020.

  • Weaver Consulting Group reported no remaining Abiomed Inc position as of Q4 2020 after selling out during the quarter.
  • Weaver Consulting Group sold 20 Abiomed Inc shares in Q4 2020, an estimated $6K.
  • Weaver Consulting Group first reported a position in Abiomed Inc in Q1 2019 and held it in 7 quarters.
  • Weaver Consulting Group's Abiomed Inc position peaked at $6K in Q3 2020.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2020.

Based on Weaver Consulting Group's 13F filing for Q4 2020, filed 29 Jan 2021.